EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway

Jing Gao, Xiaojuan Lu, Guanglei Wang, Tanling Huang, Zhongyu Tuo, Weiwei Meng

Biomolecules and Biomedicine · 2025

DOI: 10.17305/bb.2024.11550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2025. Verfasst von Jing Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, ShenZhen Baoan Shiyan People's Hospital, Guangdong Province, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Apoptosis, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous metastatic lymphoma that can be treated by targeting angiogenesis. Apolipoprotein C1 (APOC1) plays a significant role in the proliferation and metastasis of various malignant tumors; however, its role in DLBCL—particularly its effects on angiogenesis—remains largely unexplored. This study investigates the correlation between APOC1 expression and patient prognosis in DLBCL. Using APOC1 gene knockdown, apoptosis, migration, and invasion were assessed through flow cytometry, the EDU assay, wound healing, and Transwell assays. Additionally, human umbilical vein endothelial cells (HUVEC) angiogenesis was evaluated. Advanced techniques, such as immunofluorescence, TUNEL assay, and immunohistochemical labeling were employed to analyze the effects of APOC1 knockdown on the PI3K/AKT/mTOR signaling pathway and tumor formation in nude mice. Results showed that APOC1 is overexpressed in DLBCL tissues and cells, with high APOC1 levels associated with poor patient prognosis. In vitro experiments revealed that APOC1 knockdown increased apoptosis and inhibited cell proliferation, migration, invasion, HUVEC angiogenesis, and PI3K/AKT/mTOR signaling pathway protein expression in DLBCL cells. Similarly, in vivo studies demonstrated that APOC1 knockdown significantly reduced tumor growth, angiogenesis-related proteins, and phosphorylated PI3K/AKT/mTOR pathway proteins in nude mice. APOC1 knockdown promotes apoptosis and suppresses angiogenesis in DLBCL cells by inhibiting the PI3K/AKT/mTOR pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktApoptosisLymphoma, Large B-Cell, DiffusePhosphatidylinositol 3-KinasesNeovascularization, PathologicApolipoprotein C-IHumansAnimalsSignal TransductionMiceGene Knockdown TechniquesCell ProliferationCell Line, TumorMice, NudeHuman Umbilical Vein Endothelial CellsMaleFemaleCell MovementGene Expression Regulation, NeoplasticAngiogenesis

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMTOR protein, humanApolipoprotein C-I

Autor:innen und Institutionen

  • Clinical Laboratory, ShenZhen Baoan Shiyan People's Hospital, Guangdong Province, China.
  • ShenZhen Baoan Shiyan People's Hospital.

Zitieren

APA

Gao, J., Lu, X., Wang, G., Huang, T., Tuo, Z., & Meng, W. (2025). APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.11550

Vancouver

Gao J, Lu X, Wang G, Huang T, Tuo Z, Meng W. APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway. Biomolecules and Biomedicine. 2025. doi:10.17305/bb.2024.11550

BibTeX
@article{Gao2025,
  author = {Gao, Jing and Lu, Xiaojuan and Wang, Guanglei and Huang, Tanling and Tuo, Zhongyu and Meng, Weiwei},
  title = {APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  doi = {10.17305/bb.2024.11550}
}
Kostenlos starten →